The Patent Finder

Methods for Rejuvenating Red Blood Cells

Biomet Manufacturing, LLC

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 5 of these applications claim priority to application 13/756,116, filed Jan 31, 2013. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 9,102,918Methods for Rejuvenating Red Blood Cells
In force
 · Medium confidence
UsedRemaining
Biomet Manufacturing, LLCIn forceMedium confidence
US 9,103,842Methods for Rejuvenating Red Blood Cells
In force
 · Medium confidence
Biomet Manufacturing, LLCIn forceMedium confidence
US 9,808,487Methods for Rejuvenating Red Blood Cells
In force
 · High confidence
Biomet Manufacturing, LLCIn forceHigh confidence
US 9,950,012Methods for Rejuvenating Red Blood Cells
In force
 · Medium confidence
Biomet Manufacturing, LLCIn forceMedium confidence
US 10,898,520Methods for Rejuvinating Red Blood Cells
In force
 · Medium confidence
Biomet Manufacturing, LLCIn forceMedium confidence
US 9,011,408Functionally-Closed, Sterile Blood Processing Solution System and Method
In force
 · High confidence
Biomet Manufacturing, LLCIn forceHigh confidence
US 9,550,015Functionally-Closed, Sterile Blood Processing Solution System and Method
Lapsed Jan 24, 2025 on the fee record
High confidence
Biomet Manufacturing, LLCLapsed Jan 24, 2025 on the fee recordHigh confidence
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
6 of these are in force and held by Biomet Manufacturing, LLC.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited